S449 Lirentelimab (AK002) Safety and Efficacy in Patients With Higher Eosinophil Thresholds: Supplementary Analysis of Phase 2/3 EoE KRYPTOS Trial. (October 2022) - Chehade, Mirna; Genta, Robert M.; Leiman, David A.; Peterson, Kathryn A.; Spergel, Jonathan; Wechsler, Joshua; Bortey, Enoch; Chang, Alan T.; Hirano, Ikuo